Psychedelic drug development is advancing quickly, but clinical progress often stalls due to small datasets, regulatory ...

Predictive model accelerates the development of nanoparticles as potential drug carriers for targeting neurodegenerative ...

Past neuroscience studies have consistently showed the profound effects of early life experiences on the brain's wiring, particularly on the formation of the junctions that enable communication ...

Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC), an institution under the Ministry of ...

Oragenics, a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today announced a strategic collaboration with Receptor.AI, ...

A powerful editorial published today in Brain Medicine raises alarm about a previously overlooked threat to brain development and public health: the disruption of sterol biosynthesis by common ...

Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with FDA approval application planned for early next year.

Caroline Connor's concerns about her son's development began around his first birthday, when she noticed he wasn't talking or ...

Researchers employed a specialized brain imaging technique to identify a potential biomarker and therapeutic target for Long ...